Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease
Open accessThe DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Abstract
Non-alcoholic fatty liver disease (NAFLD) has been recognized as a major health burden. It is the most important cause of chronic liver disease and a major independent cardiovascular risk factor. Lacking a definite treatment for NAFLD, a specific diet and an increase in physical activity represent the most commonly used therapeutic approaches. In this review, major literature data about the use of omega-3 polyunsaturated fatty acids (n-3 PUFAs) as a potential treatment of NAFLD have been described. n-3 PUFAs, besides having a beneficial impact on most of the cardio-metabolic risk factors (hypertension, hyperlipidemia, endothelial dysfunction and atherosclerosis) by regulating gene transcription factors [i.e., peroxisome proliferator-activated receptor (PPAR) α, PPARγ, sterol regulatory element-binding protein-1, carbohydrate responsive element-binding protein], impacts both lipid metabolism and on insulin sensitivity. In addition to an enhancement of hepatic beta oxidation and a decrease of the endogenous lipid production, n-3 PUFAs are able to determine a significant reduction of the expression of pro-inflammatory molecules (tumor necrosis factor-α and interleukin-6) and of oxygen reactive species. Further strengthening the results of the in vitro studies, both animal models and human intervention trials, showed a beneficial effect of n-3 PUFAs on the severity of NAFLD as expressed by laboratory parameters and imaging measurements. Despite available results provided encouraging data about the efficacy of n-3 PUFAs as a treatment of NAFLD in humans, well-designed randomized controlled trials of adequate size and duration, with histological endpoints, are needed to assess the long-term safety and efficacy of PUFA, as well as other therapies, for the treatment of NAFLD and non-alcoholic steatohepatitis patients. It is worthwhile to consider that n-3 PUFAs cannot be synthesized by the human body and must be derived from exogenous sources (fish oil, flaxseeds, olive oil) which are typical foods of the Mediterranean diet, known for its beneficial effects in preventing obesity, diabetes and, in turn, cardiovascular events. According to these data, it is important to consider that most of the beneficial effects of n-3 PUFAs can also be obtained by an equilibrate nutrition program.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
Tilg, H., & Moschen, A. R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1937 · Cited by 3,188
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Williams, C. D., Stengel, J., Asike, M. I., Torres, D. M., Shaw, J., Contreras, M., Landt, C. L., & Harrison, S. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.09.038 · Cited by 2,148
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,610
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Starley, B. Q., Calcagno, C. J., & Harrison, S. A. (2010) · Hepatology · doi:10.1002/hep.23594 · Cited by 1,336
Molecular recognition of fatty acids by peroxisome proliferator-activated receptors
Xu, H. E., Lambert, M. H., Montana, V. G., Parks, D. J., Blanchard, S. G., Brown, P. J., Sternbach, D. D., Lehmann, J. M., Wisely, G. B., Willson, T. M., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80467-0 · Cited by 1,169
International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors
Michalik, L., Auwerx, J., Berger, J. P., Chatterjee, V. K., Glass, C. K., Gonzalez, F. J., Grimaldi, P. A., Kadowaki, T., Lazar, M. A., O’Rahilly, S., et al. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.5 · Cited by 1,000
Etiopathogenesis of Nonalcoholic Steatohepatitis
Chitturi, S., & Farrell, G. C. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12927 · Cited by 661
Zelber-Sagi, S., Nitzan-Kaluski, D., Goldsmith, R., Webb, M., Blendis, L., Halpern, Z., & Oren, R. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.06.020 · Cited by 551
Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease
Hamaguchi, M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i10.1579 · Cited by 542
Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients
VIDELA, L. A., RODRIGO, R., ORELLANA, M., FERNANDEZ, V., TAPIA, G., QUIÑONES, L., VARELA, N., CONTRERAS, J., LAZARTE, R., CSENDES, A., et al. (2004) · Clinical Science · doi:10.1042/cs20030285 · Cited by 515
Marx, N., Duez, H., Fruchart, J.-C., & Staels, B. (2004) · Circulation Research · doi:10.1161/01.res.0000127122.22685.0a · Cited by 501
Xu, J., Nakamura, M. T., Cho, H. P., & Clarke, S. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23577 · Cited by 499
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215593 · Cited by 480
N-3 polyunsaturated fatty acid regulation of hepatic gene transcription
Jump, D. B. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282ffaf6a · Cited by 443
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis
Marra, F., Gastaldelli, A., Svegliati Baroni, G., Tell, G., & Tiribelli, C. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.003 · Cited by 425
Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression
Sekiya, M., Yahagi, N., Matsuzaka, T., Najima, Y., Nakakuki, M., Nagai, R., Ishibashi, S., Osuga, J.-I., Yamada, N., & Shimano, H. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.028 · Cited by 415
CAPANNI, M., CALELLA, F., BIAGINI, M. R., GENISE, S., RAIMONDI, L., BEDOGNI, G., SVEGLIATI‐BARONI, G., SOFI, F., MILANI, S., ABBATE, R., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02885.x · Cited by 410
Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
Argo, C. K., & Caldwell, S. H. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.005 · Cited by 389
Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis
Anderson, N., & Borlak, J. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00001 · Cited by 385
Tetri, L. H., Basaranoglu, M., Brunt, E. M., Yerian, L. M., & Neuschwander-Tetri, B. A. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90272.2008 · Cited by 378
Kim, H.-J., Takahashi, M., & Ezaki, O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25892 · Cited by 377
Yahagi, N., Shimano, H., Hasty, A. H., Amemiya-Kudo, M., Okazaki, H., Tamura, Y., Iizuka, Y., Shionoiri, F., Ohashi, K., Osuga, J.-I., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35840 · Cited by 364
Stepanova, M., & Younossi, Z. M. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.12.039 · Cited by 352
Peroxisome Proliferator–Activated Receptors as Transcriptional Nodal Points and Therapeutic Targets
Brown, J. D., & Plutzky, J. (2007) · Circulation · doi:10.1161/circulationaha.104.475673 · Cited by 340
Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)
Bellentani, S., & Marino, M. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31820-4 · Cited by 322
Worgall, T. S., Sturley, S. L., Seo, T., Osborne, T. F., & Deckelbaum, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25537 · Cited by 321
Moon, Y.-A., Liang, G., Xie, X., Frank-Kamenetsky, M., Fitzgerald, K., Koteliansky, V., Brown, M. S., Goldstein, J. L., & Horton, J. D. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.017 · Cited by 320
Dentin, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25256 · Cited by 315
Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease
Spadaro, L., Magliocco, O., Spampinato, D., Piro, S., Oliveri, C., Alagona, C., Papa, G., Rabuazzo, A. M., & Purrello, F. (2008) · Digestive and Liver Disease · doi:10.1016/j.dld.2007.10.003 · Cited by 293
Nobili, V., Bedogni, G., Alisi, A., Pietrobattista, A., Rise, P., Galli, C., & Agostoni, C. (2011) · Archives of Disease in Childhood · doi:10.1136/adc.2010.192401 · Cited by 256
A Model of Insulin Resistance and Nonalcoholic Steatohepatitis in Rats
Svegliati-Baroni, G., Candelaresi, C., Saccomanno, S., Ferretti, G., Bachetti, T., Marzioni, M., De Minicis, S., Nobili, L., Salzano, R., Omenetti, A., et al. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050953 · Cited by 256
Plasma adiponectin is decreased in nonalcoholic fatty liver disease
Pagano, C., Soardo, G., Esposito, W., Fallo, F., Basan, L., Donnini, D., Federspil, G., Sechi, L. A., & Vettor, R. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01821 · Cited by 256
Highly Purified Eicosapentaenoic Acid Treatment Improves Nonalcoholic Steatohepatitis
Tanaka, N., Sano, K., Horiuchi, A., Tanaka, E., Kiyosawa, K., & Aoyama, T. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31815591aa · Cited by 248
Nagasawa, T., Inada, Y., Nakano, S., Tamura, T., Takahashi, T., Maruyama, K., Yamazaki, Y., Kuroda, J., & Shibata, N. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.02.028 · Cited by 233
The Role of Cytokines in Non-Alcoholic Fatty Liver Disease
Tilg, H. (2010) · Digestive Diseases · doi:10.1159/000282083 · Cited by 227
Yasutake, K., Nakamuta, M., Shima, Y., Ohyama, A., Masuda, K., Haruta, N., Fujino, T., Aoyagi, Y., Fukuizumi, K., Yoshimoto, T., et al. (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802588133 · Cited by 217
Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice
McCuskey, R. S., Ito, Y., Robertson, G. R., McCuskey, M. K., Perry, M., & Farrell, G. C. (2004) · Hepatology · doi:10.1002/hep.20302 · Cited by 210
O’Keefe, J. H., Abuissa, H., Sastre, A., Steinhaus, D. M., & Harris, W. S. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.11.025 · Cited by 207
Alwayn, I. P. J., Gura, K., Nosé, V., Zausche, B., Javid, P., Garza, J., Verbesey, J., Voss, S., Ollero, M., Andersson, C., et al. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000153672.43030.75 · Cited by 204
Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis†
Maher, J. J., Leon, P., & Ryan, J. C. (2008) · Hepatology · doi:10.1002/hep.22399 · Cited by 203
Kim, S. P., Ellmerer, M., Van Citters, G. W., & Bergman, R. N. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2453 · Cited by 198
Pawar, A., & Jump, D. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306238200 · Cited by 196
Peroxisome Proliferator-Activated Receptor α Protects against Obesity-Induced Hepatic Inflammation
Stienstra, R., Mandard, S., Patsouris, D., Maass, C., Kersten, S., & Müller, M. (2007) · Endocrinology · doi:10.1210/en.2007-0014 · Cited by 191
Zhu, F.-S., Liu, S., Chen, X.-M., Huang, Z.-G., & Zhang, D.-W. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.6395 · Cited by 187
Could inflammatory markers help diagnose nonalcoholic steatohepatitis?
Tarantino, G., Conca, P., Pasanisi, F., Ariello, M., Mastrolia, M., Arena, A., Tarantino, M., Scopacasa, F., & Vecchione, R. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283229b40 · Cited by 185
Non‐alcoholic fatty liver disease: Further expression of the metabolic syndrome
Tarantino, G., Saldalamacchia, G., Conca, P., & Arena, A. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04824.x · Cited by 184
Botolin, D., Wang, Y., Christian, B., & Jump, D. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500365-jlr200 · Cited by 162
Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease
Videla, L. A., Rodrigo, R., Araya, J., & Poniachik, J. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.10.001 · Cited by 159
Dietary n-3 polyunsaturated fatty acids decrease hepatic triglycerides in Fischer 344 rats
Levy, J. R., Clore, J. N., & Stevens, W. (2004) · Hepatology · doi:10.1002/hep.20093 · Cited by 155
Kallwitz, E. R., McLachlan, A., & Cotler, S. J. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.22 · Cited by 150
The Role of Liver X Receptor-α in the Fatty Acid Regulation of Hepatic Gene Expression
Pawar, A., Botolin, D., Mangelsdorf, D. J., & Jump, D. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307973200 · Cited by 146
Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms
Videla, L. A. (2009) · World Journal of Hepatology · doi:10.4254/wjh.v1.i1.72 · Cited by 144
Aronis, A., Madar, Z., & Tirosh, O. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.01.015 · Cited by 123
Sofi, F., Giangrandi, I., Cesari, F., Corsani, I., Abbate, R., Gensini, G. F., & Casini, A. (2010) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2010.487480 · Cited by 120
Pachikian, B. D., Essaghir, A., Demoulin, J., Neyrinck, A. M., Catry, É., Backer, F. C. D., Dejeans, N., Dewulf, E. M., Sohet, F. M., Portois, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023365 · Cited by 96
Ishii, H., Horie, Y., Ohshima, S., Anezaki, Y., Kinoshita, N., Dohmen, T., Kataoka, E., Sato, W., Goto, T., Sasaki, J., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.10.031 · Cited by 94
de Oliveira, C. P. M. S., Coelho, A. M. M., Barbeiro, H. V., de Lima, V. M. R., Soriano, F. G., RIBEIRO, C. F. D. S., Molan, N. A., Alves, V. A. F., de Souza, H. P., Machado, M. C. C., et al. (2006) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2006000200004 · Cited by 94
Garrel, C., Alessandri, J., Guesnet, P., & Al-Gubory, K. H. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.10.007 · Cited by 94
Molecular mechanisms of steatosis in nonalcoholic fatty liver disease.
Pettinelli, P., Obregón, A. M., & Videla, L. A. (2011) · PubMed · doi:10.1590/s0212-16112011000300003 · Cited by 85
Total Fat and (n-3):(n-6) Fat Ratios Influence Eicosanoid Production in Mice
Broughton, K. S., & Wade, J. W. (2002) · Journal of Nutrition · doi:10.1093/jn/132.1.88 · Cited by 85
Tarantino, G., Conca, P., Riccio, A., Tarantino, M., Di Minno, M. N., Chianese, D., Pasanisi, F., Contaldo, F., Scopacasa, F., & Capone, D. (2008) · Journal of Translational Medicine · doi:10.1186/1479-5876-6-72 · Cited by 83
Alwayn, I. P. J., Andersson, C., Zauscher, B., Gura, K., Nosé, V., & Puder, M. (2005) · Transplantation · doi:10.1097/01.tp.0000150023.86487.44 · Cited by 79
YEON, J. E., CHOI, K. M., BAIK, S. H., KIM, K. O., LIM, H. J., PARK, K. H., KIM, J. Y., PARK, J., KIM, J. S., BAK, Y., et al. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03349.x · Cited by 73
Mediterranean diet in healthy lifestyle and prevention of stroke.
Demarin, V., Lisak, M., & Morović, S. (2011) · PubMed · Cited by 68
High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism
Minno, M. N. D. D., Tufano, A., Rusolillo, A., Minno, G. D., & Tarantino, G. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i48.6119 · Cited by 64
Self-citationKajikawa, S., Imada, K., Takeuchi, T., Shimizu, Y., Kawashima, A., Harada, T., & Mizuguchi, K. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1400-5 · Cited by 57
Effects of N-3 Fatty Acids on Hepatic Triglyceride Content in Humans
Vega, G. L., Chandalia, M., Szczepaniak, L. S., & Grundy, S. M. (2008) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e318177024d · Cited by 56
Activation of glucokinase gene expression by hepatic nuclear factor 4α in primary hepatocytes
Ulrike, R. O. T. H., Jungermann, K. A., & Kietzmann, T. (2002) · Biochemical Journal · doi:10.1042/bj20020340 · Cited by 53
Marsman, H. A., Heger, M., Kloek, J. J., Nienhuis, S., ten Kate, F. J. W., & van Gulik, T. M. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.07.009 · Cited by 45
Harnois, D. M. (2011) · Yearbook of Gastroenterology · doi:10.1016/j.ygas.2011.07.031 · Cited by 43
Effect of diet on lipid metabolism in experimental animals and man.
Rh, H., Zakim, D., & Stifel, F. B. (1970) · PubMed · Cited by 43
Minno, M. N. D. D., Iervolino, S., Peluso, R., Russolillo, A., Lupoli, R., Scarpa, R., Minno, G. D., Tarantino, G., & the CaRRDS Study Group (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.111391 · Cited by 40
Self-citationMorphological changes of organs after sucrose or fructose feeding.
Poulsom, R. (1986) · PubMed · Cited by 40
Werner, A., Havinga, R., Kuipers, F., & Verkade, H. J. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00425.2003 · Cited by 39
Kim, H., Lee, K., Park, Y. B., Jeon, S.-M., & Choi, M. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700315 · Cited by 36
Autonomic Function, Omega-3, and Cardiovascular Risk
Abuissa, H. S., O’Keefe, J. H., Harris, W. S., & Lavie, C. J. (2005) · CHEST Journal · doi:10.1016/s0012-3692(15)34447-0 · Cited by 32
Exploring newer cardioprotective strategies: ω-3 fatty acids in perspective
Tremoli, E., Tufano, A., Russolillo, A., Lupoli, R., Minno, G. D., & Minno, M. N. D. D. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-01-0008 · Cited by 31
Self-citationEmerging drugs for non-alcoholic fatty liver disease
Federico, A., Niosi, M., Blanco, C. D. V., & Loguercio, C. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.13.1.145 · Cited by 27
Fatty Liver in Obesity: Relation to Doppler Perfusion Index Measurement of the Liver
Kakkos, S. (2000) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655200750023066 · Cited by 27
Polyunsaturated fatty acids, thrombosis and vascular disease
Minno, G. D., Tufano, A., Garofano, T., & Minno, M. N. D. D. (2002) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000073601 · Cited by 13
Self-citation
Cited by
Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis
Spahis, S., Delvin, E., Borys, J.-M., & Levy, E. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6776 · Cited by 386
Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review
Delli Bovi, A. P., Marciano, F., Mandato, C., Siano, M. A., Savoia, M., & Vajro, P. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.595371 · Cited by 289
Vallianou, N., Christodoulatos, G. S., Karampela, I., Tsilingiris, D., Magkos, F., Stratigou, T., Kounatidis, D., & Dalamaga, M. (2021) · Biomolecules · doi:10.3390/biom12010056 · Cited by 289
Hassani Zadeh, S., Mansoori, A., & Hosseinzadeh, M. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15363 · Cited by 167
Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease
Jump, D. B., Lytle, K. A., Depner, C. M., & Tripathy, S. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.07.007 · Cited by 142
“The fatty acyl composition of these complex lipids, however, is enriched in SFA and MUFA and depleted of PUFA (ω3 and ω6) (Allard, 2007; Arendt, 2015; Di Minno et al., 2012; Parker et al., 2012; Petit et al., 2012; Zheng et al., 2012).”
Background
Metadata
- Authors
- Minno, M. N. D. D.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2012
- Volume
- 18
- Issue
- 41
- Pages
- 5839
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W1497133247
- Cited by
- 174
- References
- 86
- FWCI
- 15.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.